NurExone Biologic Inc. (TSXV: NRX)

Market Cap	49.63M
Revenue (ttm)	n/a
Net Income (ttm)	-5.72M
Shares Out	70.89M
EPS (ttm)	-0.10
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	29,500
Open	0.740
Previous Close	0.720
Day's Range	0.720 - 0.740
52-Week Range	0.260 - 1.190
Beta	-0.06
Analysts	n/a
Price Target	n/a
Earnings Date	Mar 28, 2025

About NurExone Biologic

NurExone Biologic Inc., operates as a pharmaceutical technology company. It is developing an off-the-shelf, non-invasive, and novel treatment for the reversal or reduction of paralysis following spinal cord injury using membrane-bound extracellular vesicles technology, as well as to treat brain trauma injury, and other brain and neurological indications. The company was founded in 2020 and is based in Toronto, Canada.

• Industry: Biotechnology
• Sector: Healthcare
• Founded: 2020
• Country: Canada
• Stock Exchange: TSX Venture Exchange
• Ticker Symbol: NRX

Financial Performance

Financial numbers in USD